Detalles de la búsqueda
1.
Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery.
Ann Surg Oncol
; 28(7): 3637-3645, 2021 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-33221980
2.
Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort.
BMC Cancer
; 21(1): 525, 2021 May 08.
Artículo
Inglés
| MEDLINE | ID: mdl-33964923
3.
Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes.
BMC Cancer
; 19(1): 422, 2019 May 06.
Artículo
Inglés
| MEDLINE | ID: mdl-31060523
4.
Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
BMC Cancer
; 19(1): 4, 2019 Jan 03.
Artículo
Inglés
| MEDLINE | ID: mdl-30606148
5.
Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis.
BMC Cancer
; 19(1): 1194, 2019 Dec 05.
Artículo
Inglés
| MEDLINE | ID: mdl-31805898
6.
Retrospective analysis of the role of cyclin E1 overexpression as a predictive marker for the efficacy of bevacizumab in platinum-sensitive recurrent ovarian cancer.
Ecancermedicalscience
; 15: 1262, 2021.
Artículo
Inglés
| MEDLINE | ID: mdl-34567247
7.
Risk factors for pelvic and distant recurrence in locally advanced cervical cancer.
Eur J Obstet Gynecol Reprod Biol
; 235: 6-12, 2019 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-30771718
Resultados
1 -
7
de 7
1
Próxima >
>>